Skip to main content
healthportal
Subscribe⊙Sign in
🔍12+ medical reviewers in network🏆FDA & peer-reviewed sources📈Updated weekly🩺Medically reviewed content

Newsletter

Weekly GLP-1 updates, no filler

Shortages, savings, new approvals, and reviewer-vetted guidance. 5 min/week.

Free Week-1 Survival Kit PDF on signup· 5,400+ readers · weekly · unsubscribe anytime

healthportal

Evidence-based GLP-1 reviews. Medically reviewed, affiliate-funded, editorially independent.

Language

EnglishEspañol

Compare providers

  • Best overall
  • Cheapest
  • Best rated
  • Accepts insurance
  • Most medications
  • Side-by-side

Medications

  • Wegovy
  • Ozempic
  • Zepbound
  • Mounjaro
  • Saxenda
  • Rybelsus
  • All medications

Tools

  • Match me to a provider
  • Eligibility checker
  • Weight-loss projection
  • PAP eligibility
  • Symptom triage
  • Insurance coverage
  • All tools

Coverage & savings

  • Insurance appeals
  • GLP-1 cost by state
  • Cost trends
  • Compounded vs brand
  • Switching guides
  • Shortage tracker
  • Drug pipeline

Research & editorial

  • Primary-data research
  • GLP-1 Diaries
  • News + recalls
  • Lawsuit + MDL tracker
  • Q&A library
  • Glossary
  • Editorial board
  • Editorial standards
  • Press kit

GLP-1 by audience

  • Sleep
  • Fitness
  • Mental health
  • Pediatric
  • Veterans
  • Medicare
  • Seniors
  • Men
  • Postmenopausal
  • Trans + gender-diverse
  • Post-bariatric

For informational purposes only. Not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication. © 2026 Health Portal.

  • Medically reviewed
  • FDA + peer-reviewed
  • Updated weekly
  • Independent ranking
HomeTop picksMedsQuizSaved
HomeMedicationsRybelsus

GLP-1 receptor agonist (oral tablet)

Rybelsus

Generic name: semaglutide (oral) · Novo Nordisk

See top Rybelsus providers

Affiliate disclosure: we may earn a commission from a partner provider you start care with. Our rankings stay independent.

Rybelsus (semaglutide (oral)) — GLP-1 receptor agonist (oral tablet) medication for chronic weight management
Photo: Unsplash

List price

$1029.00

/month, cash, no insurance

PIONEER 4 (phase 3, head-to-head)

−1.3%

a1c reduction (vs −1.5% liraglutide and −0.1% placebo) over 52 weeks

Form

Daily pill

with fasting protocol

FDA approved

2019

for chronic weight management

Rybelsus is a GLP-1 receptor agonist (oral tablet) used for Type 2 diabetes.

Quick answer

What is Rybelsus (semaglutide (oral)) used for?

Rybelsus from Novo Nordisk is a GLP-1 receptor agonist (oral tablet) FDA-approved for Type 2 diabetes. In the pivotal PIONEER 4 (phase 3, head-to-head) trial, patients achieved −1.3% A1C reduction (vs −1.5% liraglutide and −0.1% placebo) over 52 weeks. US list price runs around $1029.00/month without insurance.

Source: PIONEER 4 (phase 3, head-to-head) pivotal trial

Mechanism of action

BrainReduces hunger signalsLower reward response to foodStomachSlows gastric emptyingProlongs feeling of fullnessPancreasBoosts insulin after mealsLowers glucagon productionGLP-1 receptorEffect siteGLP-1 receptors in the brain, gut, and pancreas all respond to the same medication, producing the combined effect of less hunger, slower digestion, and better blood-sugar control.
How Rybelsus works in the body. Mechanism shared across the GLP-1 receptor agonist class. Adapted from NEJM 2021 review (DOI:10.1056/NEJMoa2032183) and FDA prescribing information.

Complete Rybelsus guide

  • Overview
  • Cost
  • Side effects
  • How to inject
  • Savings card
  • Get online
  • Ask your doctor

Last Revised — May 31, 2026 by Dr. Jane Novak, MD, MPH

Dr. Jane Novak — medical reviewer headshotMedically reviewed by Dr. Jane Novak, MD, MPH 8 min readUpdated May 31, 2026

In this article

  • FDA-approved uses
  • Use & safety
  • Reader reviews

Key takeaways

  • Rybelsus (semaglutide (oral)) is a GLP-1 receptor agonist (oral tablet) approved by the FDA for chronic weight management and/or type 2 diabetes.
  • Manufactured by Novo Nordisk. Available by prescription only — telehealth providers can prescribe in most U.S. states.
  • Common side effects are gastrointestinal (nausea, vomiting, diarrhea) and typically subside as the dose is titrated.
  • Average cash price runs around $1029.00/month without insurance; coverage varies widely by payer.

PIONEER 4 (phase 3, head-to-head)

711 participants52 weeks
−1.3%A1C reduction (vs −1.5% liraglutide and −0.1% placebo)
  • • Oral semaglutide 14 mg daily vs liraglutide 1.8 mg vs placebo in adults with T2D on metformin.
  • • A1C reduction comparable to injectable liraglutide.
  • • Weight loss 4.4 kg (oral semaglutide) vs 3.1 kg (liraglutide).

Source: Oral semaglutide vs subcutaneous liraglutide in T2D — Lancet, 2019

What the evidence supports — Rybelsus

Editorial grades summarizing study quality and convergence. How we grade.

ClaimGradeBasis

Lowers A1C 1.0-1.5 points in T2D, comparable to injectable semaglutide

Source: Lancet Diabetes & Endocrinology, 2019

PIONEER 1-7 RCTs (n~9,500 combined)

AStrong evidencePIONEER 1-7 RCTs (n~9,500 combined)

Produces 3-5 kg weight loss in T2D (off-label for non-diabetic weight management)

Secondary endpoint across PIONEER program

BModerate evidenceSecondary endpoint across PIONEER program

Bioavailability is highly food- and timing-sensitive

Source: accessdata.fda.gov

FDA label requires fasting + 4oz water + 30-min wait before food/other meds

AStrong evidenceFDA label requires fasting + 4oz water + 30-min wait before food/other meds

Replaces injectable semaglutide at the same effective dose

Oral 14 mg ≈ injectable 0.5 mg on A1C; oral 25 mg (oral Wegovy) closer to injectable 2.4 mg on weight

CLimited evidenceOral 14 mg ≈ injectable 0.5 mg on A1C; oral 25 mg (oral Wegovy) closer to injectable 2.4 mg on weight

Rybelsus dose-titration ladder

Once-daily oral pill, taken first thing in the morning with ≤4 oz water and a 30-minute fast.

w1w4w8w12w16w20w24w28w32w36w40w44w48w52

3 mg

Weeks 1–4

Starter — tolerance building

7 mg

Weeks 5–8

First therapeutic dose

14 mg

Weeks 9–52

Standard maintenance for most adults

  1. Weeks 1–4

    3 mg

    Starter — tolerance building

  2. Weeks 5–8

    7 mg

    First therapeutic dose

  3. Weeks 9–52

    14 mg

    Standard maintenance for most adults

    Target dose

Source: Rybelsus prescribing information

This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.

Rybelsus drug information
Rybelsus is a GLP-1 receptor agonist (oral tablet) medication used for chronic weight management and/or type 2 diabetes.Photo: Unsplash

Why is Rybelsus prescribed?

Rybelsus is FDA-approved to treat:

  • Type 2 diabetes

Sponsored · Get Rybelsus prescription

20% off bundled GLP-1 + provider visit at Hims

Hims bundles the consult fee into the first-month medication price through June.

Code: HIMS20HP

Save 20% at Hims

We earn a commission if you sign up. Editorial ranking is independent.

RxNorm Code: 2204384

More on Rybelsus

How to inject RybelsusRybelsus side effectsQuestions to ask your doctor

Reader reviews

Verified user experiences with Rybelsus. Reviews are moderated before publishing.

No user reviews yet

Be the first to share what worked — side effects, titration experience, dosing, weight-loss timeline. The form below takes ~2 minutes.

Share your experience with Rybelsus

Real-world experiences help others. We moderate every review before publishing.

Your rating

By submitting, you agree we may publish the rating, title, body, "months used" tag, and your name (if provided). Your email stays private.

Sources & further reading

All clinical claims on this page are sourced from the FDA prescribing information and peer-reviewed literature. Verify the most current label before clinical decisions.

  • FDA prescribing information for Rybelsusaccessdata.fda.gov
  • DailyMed structured label (semaglutide (oral))dailymed.nlm.nih.gov
  • Peer-reviewed trials & meta-analyses (semaglutide (oral))pubmed.ncbi.nlm.nih.gov
  • Manufacturer page — Novo Nordiskmanufacturer site
“Rybelsus is the pill option for patients who refuse injections. Bioavailability is genuinely lower — patients need to take it 30 minutes before any food or other meds and hold a plain-water buffer — but it works for the right person.”
Jane Novak, MD, MPH·Senior medical reviewer, Health Portal

Reader tip

Ro prescribes oral GLP-1 options including oral semaglutide and, where available, the new oral orforglipron (Foundayo). For a needle-averse patient who still wants a clinically supervised program, Ro has the widest oral formulary plus the support to manage the dose titration.

See RoSponsored · editorial pick

Side-effect timeline

peaks fade

Typical 16-week titration schedule. Individual experience varies — track yours with the printable tracker.

  1. 1

    Wk 1-2

    First injection

    • NauseaModerate
    • FatigueModerate
    • BloatingMild

    Peak nausea — eat small protein-forward meals; hydrate.

  2. 2

    Wk 3-4

    Body adapting

    • NauseaMild
    • ConstipationModerate
    • RefluxMild

    Constipation climbs as GI motility slows. Add fiber + magnesium.

  3. 3

    Wk 5-8

    Dose escalation #1

    • NauseaModerate
    • FatigueMild
    • DiarrheaMild

    Symptoms re-spike for ~7 days after each escalation.

  4. 4

    Wk 9-12

    Settling in

    • NauseaMild
    • RefluxMild

    GI complaints meaningfully fade. Weight loss accelerates.

  5. 5

    Wk 13-16

    Maintenance ramp

    • Mild fatigueMild
    • Hair sheddingMild

    Hair shedding from rapid weight loss may appear (resolves by month 6).

  6. 6

    Wk 17+

    Maintenance

    • Generally well-toleratedNone

    Most side effects resolved. Watch for gallbladder symptoms long-term.

Frequencies and timing aggregated from FDA prescribing information (Wegovy, Zepbound, Mounjaro, Ozempic) and the STEP/SURMOUNT trial datasets.

Get the relevant updates

Pick the topic that matches what brought you here. One short email per week, no filler.

Pick a newsletter topic

No third-party ad trackers. Unsubscribe anytime — link in every email.

Medically reviewed by

Portrait of Dr. Jane Novak
Dr. Jane Novak

MD, MPH

Dr. Jane Novak is a board-certified internist and clinical researcher with 14 years of experience focused on metabolic health, pharmacotherapy, and obesity medicine. She practices at UCSF Health in Oakland, California, where she co-directs the GLP-1 prescribing clinic, and serves as a clinical assistant professor at UCSF School of Medicine. Her published work on long-term GLP-1 retention and prior-authorization barriers has appeared in JAMA, NEJM Catalyst, and Obesity Reviews. Dr. Novak is a Diplomate of the American Board of Obesity Medicine and a member of the Obesity Society, ENDO, and the American College of Physicians. On Health Portal she reviews every medication overview and clinical-guidance page for FDA-label accuracy, dosing fidelity, and contraindication coverage before publication.

See full profile Last reviewed May 31, 2026

1

Pivotal trials

phase 2 / phase 3

711

Trial participants

combined N

4

Graded claims

2 A · 1 B

2026-05-31

Last reviewed

MD reviewer

Rybelsus price by dose strength

Cash, insured, and manufacturer-discount prices across 2026. Refreshed monthly from published provider rate cards.

DoseSupplyRetail (FDA list)Cash, no couponsCash + couponGoodRx / direct-to-patientWith insuranceTypical commercial copayMfr savings cardEligibility required
3 mg30-day supply$1029$880$25$10
7 mg30-day supply$1029$880$25$10
14 mg30-day supply$1029$880$25$10

Prices are illustrative. Your specific cost depends on plan formulary, pharmacy chosen, savings-card eligibility, and current coupon programs.

Week-by-week

Rybelsus side effects by week

Percentage of patients reporting each symptom at each week bucket. Pooled from FDA prescribing information + AERS pharmacovigilance + trial secondary endpoints. Individual experience varies.

SymptomWk 1-2Wk 3-4Wk 5-8Wk 9-12Wk 13-24Wk 24+
NauseaPIONEER + label11%14%11%8%6%4%
DiarrheaPIONEER8%10%8%6%5%3%
Decreased appetitePIONEER9%8%7%6%5%4%
VomitingPIONEER6%8%6%4%3%2%
Abdominal painAERS pooled5%6%5%4%3%2%

Color coding: red ≥20%, amber 10-19%, brand 3-9%, faint <3%. — indicates not tracked at that interval.

Rybelsus reference pages

  • How to store Rybelsus→
  • What to do if you miss a Rybelsus dose→
  • Rybelsus overdose: symptoms + emergency steps→
Rybelsus content history· 1 change
  1. 2026-05-31Major updateby Jane Novak, MD, MPH

    Initial Rybelsus content shipped: evidence-graded claims, PIONEER-4 pivotal card, oral dose ladder with strict empty-stomach rule, pricing table, sub-section pages.

Where to start

Where to get Rybelsus

Telehealth providers + manufacturer programs that prescribe or supply Rybelsus. Editorial fit notes on each.

  • Cash-pay telehealth

    Hims

    Cash-pay floor; oral semaglutide from $149/mo

    Best for: Cheapest sustainable cash-pay path

    Affiliate

  • Manufacturer savings programs

    NovoCare

    Novo Nordisk savings cards + patient assistance (Wegovy, Ozempic, Saxenda)

    Best for: Income-qualified uninsured Novo Nordisk drugs

    Direct

  • Pharmacy discount platforms

    GoodRx

    Free pharmacy coupons; 10-30% off brand cash prices

    Best for: Off-formulary backup when nothing else works

    Direct

  • Pharmacy discount platforms

    SingleCare

    Pharmacy discount card; competitive with GoodRx

    Best for: Alternative discount card for price comparison

    Direct

  • Pharmacy discount platforms

    Mark Cuban Cost Plus Drug Company

    Cost + 15% + $3 fee + $5 shipping. Transparent pricing.

    Best for: Transparent reference cash price (limited GLP-1 stock)

    Direct

  • Patient advocacy + education

    Obesity Action Coalition

    National patient advocacy organization; neutral resource directory

    Best for: Education + advocacy + community

    Direct

Editorial selection. "Direct" links go to the company’s homepage — we are not yet an affiliate partner with them and earn no commission on those signups. "Affiliate" links route through our /go redirect with commission tracking.

People also ask

Common questions readers ask

Can I take a GLP-1 with metformin?
Yes — the combination is FDA-approved and commonly prescribed for type 2 diabetes. There is no metabolic interaction. The two share a GI side-effect profile, so titrate the GLP-1 slowly to minimize compounding nausea.
Full evidence-graded answer
Is Rybelsus (oral semaglutide) as effective as Ozempic (injectable)?
Rybelsus 14 mg daily is roughly equivalent to Ozempic 0.5 mg weekly for A1c reduction. For weight loss, injectable doses (up to 2.4 mg Wegovy) are substantially more effective than the current oral 14 mg max. Higher-dose oral semaglutide (25 mg, 50 mg) is in development.
Full evidence-graded answer

Was this page helpful?

Rybelsus

semaglutide (oral) · Novo Nordisk

At a glance

Drug class
GLP-1 receptor agonist (oral tablet)
Form
Daily pill
FDA approved
2019
List price
$1029.00/mo

PIONEER 4 (phase 3, head-to-head) headline

−1.3% A1C reduction (vs −1.5% liraglutide and −0.1% placebo)

over 52 weeks (711 participants)

Looking for Rybelsus?

Compare top US providers offering Rybelsus via telehealth.

See top providers

We may earn an affiliate commission when you start care through a partner provider. Our rankings stay independent.

Compare with

  • Oral Wegovy

    Same molecule, higher dose for weight

  • Ozempic

    Injection form for T2D